Treatment with Zebalurine has shown a reduction in nuclear DNMT1 levels in postmortem PD brain samples, suggesting a potential avenue for mitigating neuronal death in PD patients through the modulation of DNA methylation (Xu and Li 2012;Cheng et al. 2015). Here, DNMT1 is linked to Parkinson disease.